These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29768580)

  • 1. Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil.
    Viana PVS; Redner P; Ramos JP
    Cad Saude Publica; 2018 May; 34(5):e00048217. PubMed ID: 29768580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evolution of a group of patients with multidrug-resistant TB treated at a referral center in the city of Rio de Janeiro, Brazil.
    Siqueira HR; Freitas FA; Oliveira DN; Barreto AM; Dalcolmo MP; Albano RM
    J Bras Pneumol; 2009 Jan; 35(1):54-62. PubMed ID: 19219331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil.
    Brito RC; Mello FC; Andrade MK; Oliveira H; Costa W; Matos HJ; Lourenço MC; Rolla VC; Fonseca L; Ruffino Netto A; Kritski AL
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):24-33. PubMed ID: 20003691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic and Clinical Factors Associated with Treatment Outcomes for Drug-resistant Tuberculosis.
    de Oliveira Jeronymo Neves AC; Gomes Dos Santos AP; de Medeiros RL; de Oliveira Jeronymo AJ; Coelho Neves G; de Almeida IN; Carvalho de Queiroz Mello F; Lineu Kritski A
    Am J Trop Med Hyg; 2022 Dec; 107(6):1295-1301. PubMed ID: 36316000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.
    Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN
    BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors associated with underreporting of cases of multidrug-resistant tuberculosis in the state of Rio de Janeiro, Brazil: probabilistic database linkage].
    Silva MLBD; Durovini P; Mota P; Kritski AL
    Cad Saude Publica; 2021; 37(10):e00293920. PubMed ID: 34644761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis.
    Arroyo LH; Ramos ACV; Yamamura M; Berra TZ; Alves LS; Belchior AS; Santos DT; Alves JD; Campoy LT; Arcoverde MAM; Bollela VR; Bombarda S; Nunes C; Arcêncio RA
    Rev Saude Publica; 2019; 53():77. PubMed ID: 31553380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.
    Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC
    Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.
    Moyo S; Cox HS; Hughes J; Daniels J; Synman L; De Azevedo V; Shroufi A; Cox V; van Cutsem G
    PLoS One; 2015; 10(3):e0118919. PubMed ID: 25785451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study.
    Chiang SS; Starke JR; Miller AC; Cruz AT; Del Castillo H; Valdivia WJ; Tunque G; García F; Contreras C; Lecca L; Alarcón VA; Becerra MC
    Clin Infect Dis; 2016 Oct; 63(8):1063-71. PubMed ID: 27458026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of drug-resistant tuberculosis in children and young adolescents in Brazil.
    Bruzadelli Paulino da Costa F; Zamboni Berra T; Garcia de Almeida Ballestero J; Bartholomay Oliveira P; Maria Pelissari D; Mathias Alves Y; Carlos Vieira Ramos A; Queiroz Rocha de Paiva J; Kehinde Ayandeyi Teibo T; Alexandre Arcêncio R
    J Clin Tuberc Other Mycobact Dis; 2023 Dec; 33():100388. PubMed ID: 37588725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term outcome of multidrug-resistant TB patients in Fukujuji Hospital in Japan.
    Yoshiyama T; Morimoto K; Okumura M; Sasaki Y; Ogata H; Shiraishi Y; Kudou S
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):589-90. PubMed ID: 24902580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
    PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological profile of hospitalized patients with TB at a referral hospital in the city of Rio de Janeiro, Brazil.
    Oliveira HM; Brito RC; Kritski AL; Ruffino-Netto A
    J Bras Pneumol; 2009 Aug; 35(8):780-7. PubMed ID: 19750331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes of drug-resistant tuberculosis patients in Kenya.
    Mibei DJ; Kiarie JW; Wairia A; Kamene M; Okumu ME
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1477-1482. PubMed ID: 27776588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis.
    Kapata N; Grobusch MP; Chongwe G; Chanda-Kapata P; Ngosa W; Tembo M; Musonda S; Katemangwe P; Bates M; Mwaba P; Zumla A; Cobelens F
    Infection; 2017 Dec; 45(6):831-839. PubMed ID: 28779436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial analysis of tuberculosis cure in primary care in Rio de Janeiro, Brazil.
    Prado Junior JC; Medronho RA
    BMC Public Health; 2021 Oct; 21(1):1841. PubMed ID: 34641849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of drug-resistant tuberculosis in Brazil, 2014.
    Jacobs MG; Pinto Junior VL
    Epidemiol Serv Saude; 2020; 28(3):e2018294. PubMed ID: 32022216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.